Rüegg Pascal, Morand Grégoire B, Kudura Ken, Rupp Niels J, Hüllner Martin W, Broglie Martina A
Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland.
University of Zurich, Zurich, Switzerland.
Head Neck. 2020 Apr;42(4):660-669. doi: 10.1002/hed.26045. Epub 2019 Dec 19.
After primary chemoradiation in advanced oropharyngeal, laryngeal, and/or hypopharyngeal cancer, nodal disease may require a salvage neck dissection. However, salvage neck dissection is associated with increased morbidity and may only be necessary in case of persistence of viable tumor cells, which can be difficult to confirm and virtually impossible to exclude by fine needle aspiration cytology. We, therefore, aimed to identify predictive factors for the persistence of viable tumor cells in lymph node metastases from head and neck squamous cell cancer after chemoradiation.
We performed a retrospective review of neck dissection specimens performed after primary (chemo-)radiation for oropharyngeal, laryngeal, or hypopharyngeal squamous cell carcinoma. All patients were treated at University Hospital Zurich from 2007 to 2016.
A total of 78 patients were included. Thirty-eight patients (48.7%) had viable tumor cells in their neck dissection sample. High postradiation nodal maximum standardized uptake value (SUV ), p16 negativity, and low nodal shrinkage were predictors of viable tumor cells in salvage neck dissections (Mann-Whitney U/chi-squared test, P < .001, P = .025, and P = .042, respectively). Patients with viable tumor cells showed a significantly worse locoregional recurrence-free survival, distant metastasis-free survival, and disease-specific survival (log-rank test, P < .001).
Viable tumor cells can be predicted by high residual metabolic activity in the lymph nodes, negative p16 status, and low nodal shrinkage. Viable tumor cells in neck dissection specimens are associated with a poor survival and provide important prognostic information.
在晚期口咽癌、喉癌和/或下咽癌进行初始放化疗后,颈部淋巴结疾病可能需要挽救性颈清扫术。然而,挽救性颈清扫术会增加发病率,并且可能仅在存在存活肿瘤细胞时才必要,而这很难通过细针穿刺细胞学检查来确认,实际上也几乎无法排除。因此,我们旨在确定头颈部鳞状细胞癌放化疗后淋巴结转移中存活肿瘤细胞持续存在的预测因素。
我们对因口咽、喉或下咽鳞状细胞癌进行初始(放)化疗后所做的颈清扫标本进行了回顾性研究。所有患者均于2007年至2016年在苏黎世大学医院接受治疗。
共纳入78例患者。38例患者(48.7%)的颈清扫样本中有存活肿瘤细胞。放疗后淋巴结最大标准化摄取值(SUV)高、p16阴性以及淋巴结缩小程度低是挽救性颈清扫术中存活肿瘤细胞的预测因素(分别为曼-惠特尼U检验/卡方检验,P <.001、P = 0.025和P = 0.042)。有存活肿瘤细胞的患者局部区域无复发生存率、无远处转移生存率和疾病特异性生存率明显更差(对数秩检验,P <.001)。
可通过淋巴结中高残留代谢活性、p16阴性状态和低淋巴结缩小程度来预测存活肿瘤细胞。颈清扫标本中的存活肿瘤细胞与较差的生存率相关,并提供重要的预后信息。